OICHARTS
8 AMThe 8 AM report →

DGX

Quest Diagnostics Inc. · XNYS · 131 sessions on record
$233.07▲ +1.10 · +0.5%from $231.97 the session before · Sep 30, 2026 close · end of day
Open
$233.33
High
$236.97
Low
$230.84
Day's range
$6.12.6% of the previous close
VWAP
$234.05close −0.42% from it
Volume, shares
1.09M0.97× the 20-session average
Traded, $
$255.9M
Trades
25K44 shares per trade
Previous close
$231.97+1.10 to the close
Market cap
$25.72Bat the close of Sep 30
Day range36% of the way up
$230.84$236.97
52-week range75% of the way up
$186.23 May 8$248.84 Sep 21

−6.3% from the high · +25% from the low

Options

No listed options on DGX

Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close
131 sessions on file · from Mar 25
DGX close over the last 126 sessions, with S&P 500 rebased to the first close186.61221.91257.22axis spans 38%S&P 500DGXApr 1Jul 2Sep 30126 sessions from Apr 1 to Sep 30; the price axis spans 38 percent.

Quarterly results

consolidated · latest filed Jul 23, 2026 · SEC filings

Revenue $3.04B, +10% on a year earlier; profit $320.0M, +13% in the Jun 2026 quarter, consolidated.

Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of DGX on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue $Revenue YoYProfit $Profit YoYEPS $Market on the day
Jun 2026filed Jul 23$3.04B▲ +10%$320.0M▲ +13%2.840.0%S&P 500 +0.1% · −0.1 pp
Mar 2026filed Apr 22$2.90B▲ +9.2%$252.0M▲ +15%2.24▼ −2.2%S&P 500 −0.4% · −1.8 pp
Dec 2025filed Feb 26$2.81B▲ +7.1%$245.0M▲ +10%2.18—not reached
Sep 2025filed Oct 21$2.82B▲ +13%$245.0M▲ +8.4%2.16—not reached
Jun 2025filed Jul 23$2.76B▲ +15%$282.0M▲ +23%2.470.0%S&P 500 +0.1% · −0.1 pp
Mar 2025filed Apr 22$2.65B▲ +12%$220.0M▲ +13%1.94▼ −2.2%S&P 500 −0.4% · −1.8 pp
Dec 2024filed Feb 20$2.62B▲ +15%$222.0M▲ +16%1.95—not reached
Sep 2024filed Oct 21$2.49B▲ +8.4%$226.0M▲ +0.44%1.99—not reached
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of DGX on the consolidated basis, summed from the quarters filed
YearRevenue $Revenue YoYProfit $Profit YoYEPS $
FY25to Dec 2025$11.04B▲ +12%$992.0M▲ +14%8.75
FY24to Dec 2024$9.87B▲ +6.7%$871.0M▲ +2.0%7.69
FY23to Dec 2023$9.25B▼ −6.4%$854.0M▼ −9.7%7.49
FY22to Dec 2022$9.88B▼ −8.4%$946.0M▼ −53%7.97
FY21to Dec 2021$10.79B▲ +14%$2.00B▲ +39%15.55

Fundamentals

consolidated · filings to Jun 2026 · close $233.07 on Sep 30

DGX trades at 25 times trailing earnings, 3.4 times book value, revenue +9.9% over twelve months, a 0.74% dividend yield, market cap $25.72B.

Valuation
Market cap
$25.72Bon Sep 30
Price to earnings
25consolidated · four quarters to Jun 2026
Trailing EPS
$9.42diluted · consolidated · four quarters to Jun 2026
Price to book
3.4consolidated · balance sheet to Jun 2026
Book value a share
$68.10consolidated · balance sheet to Jun 2026
Debt to equity
0.75borrowings over equity · consolidated · balance sheet to Jun 2026
Return on equity
14%trailing profit over average equity · consolidated
Dividend yield
0.74%$1.72 a share in 365 days
Price to sales
2.2market cap over revenue, four quarters to Jun 2026
Shares outstanding
110Mon Sep 30
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
$11.56Bfour quarters to Jun 2026
Revenue growth, 12 months
▲ +9.9%against the twelve months before
Revenue 3-year CAGR
▲ +6.8%trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
$1.06Bfour quarters to Jun 2026
Profit growth, 12 months
▲ +12%against the twelve months before
Profit 3-year CAGR
▲ +10%trailing twelve months against the twelve months 3 years earlier · consolidated

Shareholding

quarter to Jun 2026 · SEC Form 13F

13F managers hold 180% of shares, BlackRock, Inc. the largest at 17%, VANGUARD CAPITAL MANAGEMENT LLC 13% and VANGUARD PORTFOLIO MANAGEMENT LLC 11%, as filed for the quarter to Jun 2026.

Held by 13F managers
180%of shares outstanding
Shares held
194M+1.7% on Mar 2026 among managers filing both
Managers holding
1,0371,000 a quarter earlier
Largest holder
17%BlackRock, Inc.
Largest 10 holderspercent of shares outstanding · change in shares against the previous quarter
Largest 13F holders of DGX
ManagerSharesOf outstandingValueChange on quarter
BlackRock, Inc.18.6M17%$3.93B+206K
VANGUARD CAPITAL MANAGEMENT LLC14.5M13%$3.07B+175K
VANGUARD PORTFOLIO MANAGEMENT LLC12.3M11%$2.60B+99.3K
STATE STREET CORP11M10%$2.34B+272K
Boston Partners9.49M8.6%$2.01B+1.46M
JPMORGAN CHASE & CO7.04M6.4%$1.50B—
GEODE CAPITAL MANAGEMENT, LLC6.28M5.7%$1.33B+103K
MORGAN STANLEY4.92M4.5%$1.04B−38.4K
EdgePoint Investment Group Inc.4.5M4.1%$952.7M+7.4K
DIMENSIONAL FUND ADVISORS LP3.98M3.6%$842.8M+77K
Insider tradesSEC Forms 3, 4 and 5 · the latest 10

No open-market insider buying or selling in the last 90 days.

DGX insider trades
InsiderTradeSharesPriceHeld after
KUPPUSAMY KARTHIKOfficerexercised · Jun 4, 20264,827$121.8121,657
KUPPUSAMY KARTHIKOfficerexercised · Jun 4, 20263,320$127.7316,830
KUPPUSAMY KARTHIKOfficersold · Jun 4, 20268,147$200.0013,510
Davis J. E.Director,Officersold · Jun 1, 202610,000$194.14132,423
PFEIFFER GARY MDirectorgranted · May 20, 20261,142$0.0031,005
MAIN TIMOTHY LDirectorgranted · May 20, 20261,142$0.0027,439
CARTER ROBERT BDirectorgranted · May 20, 20261,142$0.003,853
RING TIMOTHY MDirectorgranted · May 20, 20261,142$0.0031,140
MORRISON DENISE MDirectorgranted · May 20, 20261,142$0.0011,929
WENTWORTH TIMOTHY CDirectorgranted · May 20, 20261,142$0.001,358

Corporate actions

exchange records

Nothing upcoming on record; the last was a dividend of $0.86 a share, ex-date Jul 8, 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in dollars a share, splits as ratios
Corporate actions of DGX, upcoming first, then the most recent
Ex-dateActionAmount or ratioRecord date
recent
Jul 8, 2026dividend$0.86—
Apr 6, 2026dividend$0.86—
Calendardividends by ex-date
Dividends in 365 days
$1.72a share · ex-dates inside the year
Last dividend
$0.86ex-date Jul 8, 2026

Price history

131 sessions on record · to Sep 30 · end of day

DGX is −1.3% over 20 sessions against the S&P 500's +0.1%, 6.3% below its 52-week high, realised volatility 27% annualised.

Returns against S&P 500longest window first · S&P 500 over the same sessions
Returns of the stock and S&P 500 over six windows, longest first
WindowFrom $DGX %S&P 500 %Difference pp
120 sessionssince Apr 9$197.82▲ +18%▲ +12%+5.7
60 sessionssince Jul 7$212.38▲ +9.7%▲ +2.0%+7.7
20 sessionssince Sep 1$236.21▼ −1.3%▲ +0.11%−1.4
5 sessionssince Sep 23$233.00+0.03%▼ −0.67%+0.70
1 sessionsince Sep 29$231.98▲ +0.47%▼ −0.21%+0.68
Averages of the closeclose against each average
5-session average
$235.11close −0.87% from it
20-session average
$238.43close −2.2% from it
50-session average
$237.25close −1.8% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
$6.02.6% of the close
Average day's range, 20
$5.42.3% of the close
Volume against 20 sessions
0.97×1.09M vs 1.14M average
Volatility and co-movement with S&P 500annualised from daily returns
Realised volatility, 20
27%≈ ±1.7% a session · moved more than that on 5 of 20
Realised volatility, 60
27%≈ ±1.7% a session · moved more than that on 12 of 60
Beta to S&P 500, 60
-0.38moved with S&P 500 on 31 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
8 up · 11 downof 19
Last 60 sessions
24 up · 35 downof 59
Best session, 250
▲ +8.6%Jul 23
Worst session, 250
▼ −4.1%Sep 22

Quest Diagnostics Inc. is held by

1 headlines on DGX

latest Sep 24, 2026 · links go to the publisher

Short-sale volume

25 sessions · to Sep 30, 2026

Short sales were 53% of reported volume on Sep 30, 2026, against 64% over the last 25 sessions.

Last 10 sessionsshare of the day's reported volume
DGX daily short-sale volume
SessionShort volumeReported volumeShort share
Sep 30, 2026232K438K53.1%
Sep 29, 2026265K616K43.1%
Sep 28, 2026167K399K41.8%
Sep 25, 2026215K330K65.1%
Sep 24, 2026273K446K61.3%
Sep 23, 2026263K459K57.3%
Sep 22, 2026526K1.28M41.1%
Sep 21, 2026258K320K80.7%
Sep 18, 2026385K423K90.8%
Sep 17, 2026302K381K79.1%

Filings

SEC EDGAR · newest first
DGX SEC filings
FiledFormReport date
Sep 3, 20264Sep 1, 2026
Sep 1, 2026144—
Aug 31, 20264Aug 28, 2026
Aug 28, 2026144—
Aug 14, 2026SCHEDULE 13G/A—
Jul 29, 20264Jul 28, 2026
Jul 28, 2026144—
Jul 27, 20264Jul 22, 2026
Jul 27, 20264Jul 22, 2026
Jul 27, 20264Jul 22, 2026
Jul 27, 20264Jul 22, 2026
Jul 27, 20264Jul 22, 2026
Jul 27, 20264Jul 22, 2026
Jul 27, 20264Jul 22, 2026
Jul 27, 20264Jul 22, 2026
Jul 23, 202610-QJun 30, 2026
Jul 23, 20268-KJul 23, 2026
Jul 2, 20264Jul 1, 2026
Jun 18, 202611-KDec 31, 2025
Jun 8, 20264Jun 4, 2026
Jun 4, 2026144—
Jun 2, 20264Jun 1, 2026
Jun 1, 2026144—
May 21, 20264May 20, 2026
May 21, 20264May 20, 2026

About Quest Diagnostics Inc.

SEC and exchange records
Company
Quest Diagnostics Inc.
Exchange
XNYS
SEC CIK
1022079
Sessions on record
131
Price source
End of day · delayed
Computed
1 Oct, 10:35 pm IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.